LUTHERVILLE, Md., April 10, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today lauded the latest quarterly results achieved by the real-time, stop-sale system in Indiana. Data released by the National Precursor Log Exchange (NPLEx) shows electronic technology in the Hoosier State during the first quarter of 2012 blocked the sale of more than 30,600 boxes of medicines containing pseudoephedrine (PSE) preventing more than 70,000 grams from potentially being diverted by meth criminals. NPLEx was fully implemented in Indiana in January 2012.
"In a very short period of time, Indiana's real-time, stop-sale technology is proving to be an undeniable success. With NPLEx, law enforcement officials and pharmacists are provided with an effective tool that allows them to block illegal sales of safe and effective medicines containing pseudoephedrine and track down individuals who misuse nonprescription medicines to make meth," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI).
"NPLEx is a reasonable alternative to a prescription mandate, which would burden millions of Hoosiers resulting in increased healthcare costs and further doctor shortages. Thankfully, as the latest block numbers indicate, the technology is working extremely well."
The National Association of Drug Diversion Investigators (NADDI) is a nonprofit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, and pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
SOURCE National Association of Drug Diversion Investigators